Multiple sclerosis in a patient with Takayasu's Arteritis: A case report.

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL
Caspian Journal of Internal Medicine Pub Date : 2024-09-07 eCollection Date: 2024-01-01 DOI:10.22088/cjim.15.4.729
Mohammad Mehdi Emam, Mahdiye Abiyarghamsari, Muhanna Kazempour, Maryam Haghighi-Morad, Farane Farsad
{"title":"Multiple sclerosis in a patient with Takayasu's Arteritis: A case report.","authors":"Mohammad Mehdi Emam, Mahdiye Abiyarghamsari, Muhanna Kazempour, Maryam Haghighi-Morad, Farane Farsad","doi":"10.22088/cjim.15.4.729","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple sclerosis (MS) and Takayasu's arteritis (TAK) are two autoimmune diseases that affect the Central nervous system (CNS), but the relationship between them has not been established.</p><p><strong>Case presentation: </strong>Here we report the emergence of MS during treatment. Takayasu's arteritis in a 24-year-old Iranian woman with a severe presentation. She was treated aggressively with IV methylprednisolone 1 g/day for 3 days and continued with oral prednisolone, also IV cyclophosphamide monthly. After 2 months, loss of vision led to a diagnosis of Optic neuritis (ON) caused by concomitant MS.</p><p><strong>Conclusion: </strong>Differentiating CNS vasculitis associated with Takayasu's arthritis from coexisting MS affecting the CNS is challenging and what is important is to avoid giving a TNF inhibitor.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"15 4","pages":"729-734"},"PeriodicalIF":0.8000,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444114/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Caspian Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22088/cjim.15.4.729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multiple sclerosis (MS) and Takayasu's arteritis (TAK) are two autoimmune diseases that affect the Central nervous system (CNS), but the relationship between them has not been established.

Case presentation: Here we report the emergence of MS during treatment. Takayasu's arteritis in a 24-year-old Iranian woman with a severe presentation. She was treated aggressively with IV methylprednisolone 1 g/day for 3 days and continued with oral prednisolone, also IV cyclophosphamide monthly. After 2 months, loss of vision led to a diagnosis of Optic neuritis (ON) caused by concomitant MS.

Conclusion: Differentiating CNS vasculitis associated with Takayasu's arthritis from coexisting MS affecting the CNS is challenging and what is important is to avoid giving a TNF inhibitor.

一名高安动脉炎患者的多发性硬化症:病例报告。
背景:多发性硬化症(MS)和高安氏动脉炎(TAK)是影响中枢神经系统(CNS)的两种自身免疫性疾病,但它们之间的关系尚未确定:我们在此报告在治疗过程中出现的多发性硬化症。病例介绍:我们在此报告了一名 24 岁伊朗女性在治疗过程中出现的 MS。她接受了为期 3 天、每天 1 克甲基强的松龙静脉注射的积极治疗,并继续口服强的松龙,同时每月静脉注射环磷酰胺。2 个月后,由于视力下降,她被诊断为多发性硬化症并发的视神经炎(ON):结论:将与高安关节炎相关的中枢神经系统血管炎与并存的影响中枢神经系统的多发性硬化症区分开来具有挑战性,重要的是避免使用 TNF 抑制剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Caspian Journal of Internal Medicine
Caspian Journal of Internal Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
1.90
自引率
7.10%
发文量
90
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信